{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:51:39Z","timestamp":1785527499355,"version":"3.56.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373844"],"award-info":[{"award-number":["82373844"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Jiao Tong University School of Medicine High level Local University Construction of Integrated Traditional Chinese and Western Medicine Research Platform Construction Project","award":["ZXY25001"],"award-info":[{"award-number":["ZXY25001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and synaptic dysfunction. Increasing evidence suggests that impaired glucose utilization is a major contributor to AD pathogenesis. Neurons preferentially use glucose through the pentose phosphate pathway (PPP). In AD, the flux through the PPP is significantly reduced; however, the underlying mechanism is still elusive. This study was aimed to elucidate how PPP was affected in AD and its contribution to the AD pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Proteomic analyses of temporal cortex synaptosomes from AD patients and controls were conducted to identify dysregulated pathways and significantly affected proteins. Functional analysis was performed by knockdown or restoration of protein expression in primary cultured neurons, as well as in wild-type and 5\u2009\u00d7\u2009FAD mice. Pseudotargeted metabolomics and biochemical, molecular, electrophysiological and behavioral assessments were performed to evaluate metabolic characteristics, redox status, mitochondrial function, synaptic plasticity and cognition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Proteomic analysis of synaptic compartments identified glucose metabolism as the most significantly dysregulated functional network in AD. Further, transaldolase 1 (TALDO1), a rate-limiting enzyme in the PPP, was identified as a key enzyme affected in AD. TALDO1 was markedly downregulated at the early stage of AD. Downregulation of TALDO1 reduced glucose metabolism by inhibiting the PPP, TCA cycle and oxidative phosphorylation, causing broad metabolic collapse. Further, downregulation of TALDO1 depleted the nicotinamide adenine dinucleotide phosphate and glutathione pools, weakening antioxidant defense, thus resulting in mitochondria impairment and reduced energy supply. These collectively drive synaptic dysfunction and cognitive decline. Conversely, restoring TALDO1 expression in 5\u2009\u00d7\u2009FAD mice improved glucose uptake, mitigated oxidative stress, restored metabolic homeostasis, and rescued neuronal and cognitive functions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings identify TALDO1 as a key regulator of the impaired PPP in AD and may represent a promising therapeutic target for restoring neuronal metabolic homeostasis and function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40035-026-00567-z","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:17:51Z","timestamp":1785309471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transaldolase 1 contributes to pentose phosphate pathway disruption and synaptic dysfunction in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"15","author":[{"given":"Xiaoyu","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haorui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"4","key":"567_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70235","volume":"21","author":"Alzheimer\u2019s disease facts and figures","year":"2025","unstructured":"Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2025;21(4):e70235.","journal-title":"Alzheimers Dement"},{"key":"567_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102775","volume":"109","author":"VV Sugandhi","year":"2025","unstructured":"Sugandhi VV, Gadhave DG, Ugale AR, Kulkarni N, Nangare SN, Patil HP, et al. Advances in Alzheimer\u2019s therapy: Exploring neuropathological mechanisms to revolutionize the future therapeutic landscape. Ageing Res Rev. 2025;109:102775.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"567_CR3","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1002\/alz.13604","volume":"20","author":"M Darricau","year":"2023","unstructured":"Darricau M, Dou C, Kinet R, Zhu T, Zhou L, Li X, et al. Tau seeds from Alzheimer\u2019s disease brains trigger tau spread in macaques while oligomeric-Abeta mediates pathology maturation. Alzheimers Dement. 2023;20(3):1894\u2013912.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"567_CR4","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/s41380-022-01565-z","volume":"27","author":"L Peng","year":"2022","unstructured":"Peng L, Bestard-Lorigados I, Song W. The synapse as a treatment avenue for Alzheimer\u2019s disease. Mol Psychiatry. 2022;27(7):2940\u20139.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"567_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-024-00432-x","volume":"13","author":"E Liu","year":"2024","unstructured":"Liu E, Zhang Y, Wang JZ. Updates in Alzheimer\u2019s disease: from basic research to diagnosis and therapies. Transl Neurodegener. 2024;13(1):45.","journal-title":"Transl Neurodegener"},{"issue":"2","key":"567_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/jon.12264","volume":"26","author":"S Verclytte","year":"2016","unstructured":"Verclytte S, Lopes R, Lenfant P, Rollin A, Semah F, Leclerc X, et al. Cerebral hypoperfusion and hypometabolism detected by arterial spin labeling MRI and FDG-PET in early-onset Alzheimer\u2019s disease. J Neuroimaging. 2016;26(2):207\u201312.","journal-title":"J Neuroimaging"},{"issue":"47","key":"567_CR7","doi-asserted-by":"publisher","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","volume":"29","author":"AD Cohen","year":"2009","unstructured":"Cohen AD, Price JC, Weissfeld LA, James J, Rosario BL, Bi W, et al. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci. 2009;29(47):14770\u20138.","journal-title":"J Neurosci"},{"key":"567_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1196\/annals.1427.007","volume":"1147","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Pupi A, De Leon MJ. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease. Ann N Y Acad Sci. 2008;1147:180\u201395.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"567_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1152\/physrev.00062.2017","volume":"99","author":"GA Dienel","year":"2019","unstructured":"Dienel GA. Brain glucose metabolism: integration of energetics with function. Physiol Rev. 2019;99(1):949\u20131045.","journal-title":"Physiol Rev"},{"issue":"41","key":"567_CR10","doi-asserted-by":"publisher","first-page":"17763","DOI":"10.1073\/pnas.1010461107","volume":"107","author":"AG Vlassenko","year":"2010","unstructured":"Vlassenko AG, Vaishnavi SN, Couture L, Sacco D, Shannon BJ, Mach RH, et al. Spatial correlation between brain aerobic glycolysis and amyloid-\u03b2 (A\u03b2) deposition. Proc Natl Acad Sci U S A. 2010;107(41):17763\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"567_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148\u201360.","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"567_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2020;19(9):609\u201333.","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"567_CR13","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cmet.2022.07.014","volume":"34","author":"L Traxler","year":"2022","unstructured":"Traxler L, Herdy JR, Stefanoni D, Eichhorner S, Pelucchi S, Szucs A, et al. Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer\u2019s disease. Cell Metab. 2022;34(9):1248\u201363.","journal-title":"Cell Metab"},{"key":"567_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115887","author":"R Han","year":"2021","unstructured":"Han R, Liang J, Zhou B. Glucose Metabolic dysfunction in neurodegenerative diseases-new mechanistic insights and the potential of hypoxia as a prospective therapy targeting metabolic reprogramming. Int J Mol Sci. 2021;22(11):5887.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"567_CR15","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.15252\/embj.201695810","volume":"36","author":"S Camandola","year":"2017","unstructured":"Camandola S, Mattson MP. Brain metabolism in health, aging, and neurodegeneration. EMBO J. 2017;36(11):1474\u201392.","journal-title":"EMBO J"},{"issue":"6","key":"567_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/ncb1881","volume":"11","author":"A Herrero-Mendez","year":"2009","unstructured":"Herrero-Mendez A, Almeida A, Fernandez E, Maestre C, Moncada S, Bolanos JP. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC\/C-Cdh1. Nat Cell Biol. 2009;11(6):747\u201352.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"567_CR17","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.3390\/ijms23084351","volume":"23","author":"Q Wang","year":"2022","unstructured":"Wang Q, Duan L, Li X, Wang Y, Guo W, Guan F, et al. Glucose metabolism, neural cell senescence and Alzheimer\u2019s disease. Int J Mol Sci. 2022;23(8):4351\u201368.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"567_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3233\/JAD-122449","volume":"41","author":"V Tiwari","year":"2014","unstructured":"Tiwari V, Patel AB. Pyruvate carboxylase and pentose phosphate fluxes are reduced in AbetaPP-PS1 mouse model of Alzheimer\u2019s disease: a (1)(3)C NMR study. J Alzheimers Dis. 2014;41(2):387\u201399.","journal-title":"J Alzheimers Dis"},{"key":"567_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103242","volume":"75","author":"AG Correas","year":"2024","unstructured":"Correas AG, Olaso-Gonzalez G, Roca M, Blanco-Gand\u00eda MC, Nascimento C, Lahoz A, et al. Glucose 6 phosphate dehydrogenase overexpression rescues the loss of cognition in the double transgenic APP\/PS1 mouse model of Alzheimer\u2019s disease. Redox Biol. 2024;75:103242.","journal-title":"Redox Biol"},{"issue":"7","key":"567_CR20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s42255-025-01314-w","volume":"7","author":"S Bar","year":"2025","unstructured":"Bar S, Wilson KA, Hilsabeck TAU, Alderfer S, Dammer EB, Burton JB, et al. Neuronal glycogen breakdown mitigates tauopathy via pentose-phosphate-pathway-mediated oxidative stress reduction. Nat Metab. 2025;7(7):1375\u201391.","journal-title":"Nat Metab"},{"issue":"2","key":"567_CR21","first-page":"196","volume":"14","author":"AB Reiss","year":"2024","unstructured":"Reiss AB, Gulkarov S, Jacob B, Srivastava A, Pinkhasov A, Gomolin IH, et al. mitochondria in Alzheimer\u2019s disease pathogenesis. Life (Basel). 2024;14(2):196.","journal-title":"Life (Basel)"},{"issue":"1","key":"567_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-024-00409-w","volume":"13","author":"N Song","year":"2024","unstructured":"Song N, Mei S, Wang X, Hu G, Lu M. Focusing on mitochondria in the brain: from biology to therapeutics. Translational Neurodegener. 2024;13(1):23.","journal-title":"Translational Neurodegener"},{"key":"567_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2009.05.029","volume":"1286","author":"VV Dukhande","year":"2009","unstructured":"Dukhande VV, Isaac AO, Chatterji T, Lai JC. Reduced glutathione regenerating enzymes undergo developmental decline and sexual dimorphism in the rat cerebral cortex. Brain Res. 2009;1286:19\u201324.","journal-title":"Brain Res"},{"issue":"5\u20136","key":"567_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s007020050174","volume":"106","author":"M Bigl","year":"1999","unstructured":"Bigl M, Br\u00fcckner MK, Arendt T, Bigl V, Eschrich K. Activities of key glycolytic enzymes in the brains of patients with Alzheimer\u2019s disease. J Neural Transm (Vienna). 1999;106(5\u20136):499\u2013511.","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"567_CR25","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1471-4159.1986.tb00615.x","volume":"46","author":"RN Martins","year":"1986","unstructured":"Martins RN, Harper CG, Stokes GB, Masters CL. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer\u2019s disease may reflect oxidative stress. J Neurochem. 1986;46(4):1042\u20135.","journal-title":"J Neurochem"},{"issue":"2","key":"567_CR26","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1006\/abbi.1999.1404","volume":"370","author":"RL Russell","year":"1999","unstructured":"Russell RL, Siedlak SL, Raina AK, Bautista JM, Smith MA, Perry G. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys. 1999;370(2):236\u20139.","journal-title":"Arch Biochem Biophys"},{"key":"567_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105799","volume":"171","author":"K Ramamoorthy","year":"2022","unstructured":"Ramamoorthy K, Yoshimura R, Al-Juburi S, Anandam KY, Kapadia R, Alachkar A, et al. Alzheimer\u2019s disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation. Neurobiol Dis. 2022;171:105799.","journal-title":"Neurobiol Dis"},{"issue":"7","key":"567_CR28","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1007\/s12035-016-0079-9","volume":"54","author":"D Liu","year":"2017","unstructured":"Liu D, Ke Z, Luo J. Thiamine deficiency and neurodegeneration: the interplay among oxidative stress, endoplasmic reticulum stress, and autophagy. Mol Neurobiol. 2017;54(7):5440\u20138.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"567_CR29","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3233\/JAD-160841","volume":"55","author":"L Szablewski","year":"2017","unstructured":"Szablewski L. Glucose transporters in brain: in health and in Alzheimer\u2019s disease. J Alzheimers Dis. 2017;55(4):1307\u201320.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"567_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","volume":"14","author":"Y An","year":"2018","unstructured":"An Y, Varma VR, Varma S, Casanova R, Dammer E, Pletnikova O, et al. Evidence for brain glucose dysregulation in Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(3):318\u201329.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"567_CR31","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H. Glucose transporters in brain in health and disease. Pflugers Arch. 2020;472(9):1299\u2013343.","journal-title":"Pflugers Arch"},{"issue":"40","key":"567_CR32","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1073\/pnas.0602678103","volume":"103","author":"A Perl","year":"2006","unstructured":"Perl A, Qian Y, Chohan KR, Shirley CR, Amidon W, Banerjee S, et al. Transaldolase is essential for maintenance of the mitochondrial transmembrane potential and fertility of spermatozoa. Proc Natl Acad Sci U S A. 2006;103(40):14813\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"567_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1042\/BJ20080722","volume":"415","author":"Y Qian","year":"2008","unstructured":"Qian Y, Banerjee S, Grossman CE, Amidon W, Nagy G, Barcza M, et al. Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing. Biochem J. 2008;415(1):123\u201334.","journal-title":"Biochem J"},{"issue":"6","key":"567_CR34","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1172\/JCI35722","volume":"119","author":"R Hanczko","year":"2009","unstructured":"Hanczko R, Fernandez DR, Doherty E, Qian Y, Vas G, Niland B, et al. Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest. 2009;119(6):1546\u201357.","journal-title":"J Clin Invest"},{"issue":"11","key":"567_CR35","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.bbadis.2010.06.007","volume":"1802","author":"UF Engelke","year":"2010","unstructured":"Engelke UF, Zijlstra FS, Mochel F, Valayannopoulos V, Rabier D, Kluijtmans LA, et al. Mitochondrial involvement and erythronic acid as a novel biomarker in transaldolase deficiency. Biochim Biophys Acta. 2010;1802(11):1028\u201335.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"567_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-022-00334-w","volume":"12","author":"JB Li","year":"2023","unstructured":"Li JB, Hu XY, Chen MW, Xiong CH, Zhao N, Ge YH, et al. p85S6K sustains synaptic GluA1 to ameliorate cognitive deficits in Alzheimer\u2019s disease. Transl Neurodegener. 2023;12(1):1.","journal-title":"Transl Neurodegener"},{"issue":"5","key":"567_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6(5):359\u201362.","journal-title":"Nat Methods"},{"issue":"5","key":"567_CR38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.molcel.2017.01.004","volume":"65","author":"X Zhang","year":"2017","unstructured":"Zhang X, Smits AH, van Tilburg GB, Jansen PW, Makowski MM, Ovaa H, et al. An interaction landscape of ubiquitin signaling. Mol cell. 2017;65(5):941\u201355.","journal-title":"Mol cell"},{"issue":"12","key":"567_CR39","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc. 2016;11(12):2301\u201319.","journal-title":"Nat Protoc"},{"issue":"3","key":"567_CR40","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nprot.2017.147","volume":"13","author":"X Zhang","year":"2018","unstructured":"Zhang X, Smits AH, van Tilburg GB, Ovaa H, Huber W, Vermeulen M. Proteome-wide identification of ubiquitin interactions using UbIA-MS. Nat Protoc. 2018;13(3):530\u201350.","journal-title":"Nat Protoc"},{"issue":"1","key":"567_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-017-0176-x","volume":"12","author":"T Miyamoto","year":"2017","unstructured":"Miyamoto T, Stein L, Thomas R, Djukic B, Taneja P, Knox J, et al. Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture. Mol Neurodegener. 2017;12(1):41.","journal-title":"Mol Neurodegener"},{"key":"567_CR42","volume":"126","author":"LM Lueptow","year":"2017","unstructured":"Lueptow LM. Novel object recognition test for the investigation of learning and memory in mice. J Vis Exp. 2017;126:e55718.","journal-title":"J Vis Exp"},{"issue":"11","key":"567_CR43","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.biopsych.2015.04.019","volume":"79","author":"C Kibaly","year":"2016","unstructured":"Kibaly C, Kam AY, Loh HH, Law PY. Naltrexone facilitates learning and delays extinction by increasing AMPA receptor phosphorylation and membrane insertion. Biol Psychiatry. 2016;79(11):906\u201316.","journal-title":"Biol Psychiatry"},{"key":"567_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuropharm.2018.03.002","volume":"135","author":"Y Duan","year":"2018","unstructured":"Duan Y, Wang Q, Zeng Q, Wang J, Chen Z, Xu M, et al. Striatal GluN2B involved in motor skill learning and stimulus-response learning. Neuropharmacology. 2018;135:73\u201385.","journal-title":"Neuropharmacology"},{"issue":"10","key":"567_CR45","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.1111\/dom.16641","volume":"27","author":"D Jia","year":"2025","unstructured":"Jia D, Li M, Li L, Wang Q, Zhu XC, Luo J, et al. Molecular signatures of brain glycolysis dysfunction in Alzheimer\u2019s disease. Diabetes Obes Metab. 2025;27(10):5852\u201364.","journal-title":"Diabetes Obes Metab"},{"key":"567_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25189950","author":"V Padalko","year":"2024","unstructured":"Padalko V, Posnik F, Adamczyk M. Mitochondrial aconitase and its contribution to the pathogenesis of neurodegenerative diseases. Int J Mol Sci. 2024;25(18):9950.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"567_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab053","volume":"3","author":"T Niccoli","year":"2021","unstructured":"Niccoli T, Kerr F, Snoeren I, Fabian D, Aleyakpo B, Ivanov D, et al. Activating transcription factor 4-dependent lactate dehydrogenase activation as a protective response to amyloid beta toxicity. Brain Communications. 2021;3(2):fcab053.","journal-title":"Brain Communications"},{"key":"567_CR48","doi-asserted-by":"publisher","first-page":"1206688","DOI":"10.3389\/fnins.2023.1206688","volume":"17","author":"D Jia","year":"2023","unstructured":"Jia D, Wang F, Yu H. Systemic alterations of tricarboxylic acid cycle enzymes in Alzheimer\u2019s disease. Front Neurosci. 2023;17:1206688.","journal-title":"Front Neurosci"},{"issue":"12","key":"567_CR49","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/jnen\/nly102","volume":"77","author":"M Zhang","year":"2018","unstructured":"Zhang M, Cheng X, Dang R, Zhang W, Zhang J, Yao Z. Lactate deficit in an Alzheimer disease mouse model: the relationship with neuronal damage. J Neuropathol Exp Neurol. 2018;77(12):1163\u201376.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"567_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"18","key":"567_CR51","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","volume":"81","author":"E Trefts","year":"2021","unstructured":"Trefts E, Shaw RJ. AMPK: restoring metabolic homeostasis over space and time. Mol Cell. 2021;81(18):3677\u201390.","journal-title":"Mol Cell"},{"issue":"11","key":"567_CR52","doi-asserted-by":"publisher","first-page":"7653","DOI":"10.1002\/jcp.29682","volume":"235","author":"BL Tang","year":"2020","unstructured":"Tang BL. Glucose, glycolysis, and neurodegenerative diseases. J Cell Physiol. 2020;235(11):7653\u201362.","journal-title":"J Cell Physiol"},{"issue":"1","key":"567_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13195-022-00961-5","volume":"14","author":"JJ Chen","year":"2022","unstructured":"Chen JJ, Thiyagarajah M, Song J, Chen C, Herrmann N, Gallagher D, et al. Altered central and blood glutathione in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis. Alzheimers Res Ther. 2022;14(1):23.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"567_CR54","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2013.12.012","volume":"88","author":"SM de la Monte","year":"2014","unstructured":"de la Monte SM, Tong M. Brain metabolic dysfunction at the core of Alzheimer\u2019s disease. Biochem Pharmacol. 2014;88(4):548\u201359.","journal-title":"Biochem Pharmacol"},{"key":"567_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103048","volume":"70","author":"N Yu","year":"2024","unstructured":"Yu N, Pasha M, Chua JJE. Redox changes and cellular senescence in Alzheimer\u2019s disease. Redox Biol. 2024;70:103048.","journal-title":"Redox Biol"},{"key":"567_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/bs.apcsb.2023.02.016","volume":"136","author":"K Sharma","year":"2023","unstructured":"Sharma K, Sarkar J, Trisal A, Ghosh R, Dixit A, Singh AK. Targeting mitochondrial dysfunction to salvage cellular senescence for managing neurodegeneration. Adv Protein Chem Struct Biol. 2023;136:309\u201337.","journal-title":"Adv Protein Chem Struct Biol"},{"key":"567_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101503","volume":"72","author":"T Song","year":"2021","unstructured":"Song T, Song X, Zhu C, Patrick R, Skurla M, Santangelo I, et al. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer\u2019s disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies. Ageing Res Rev. 2021;72:101503.","journal-title":"Ageing Res Rev"},{"issue":"10","key":"567_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101556","volume":"23","author":"JF Navarro","year":"2020","unstructured":"Navarro JF, Croteau DL, Jurek A, Andrusivova Z, Yang B, Wang Y, et al. Spatial transcriptomics reveals genes associated with dysregulated mitochondrial functions and stress signaling in Alzheimer disease. iScience. 2020;23(10):101556.","journal-title":"iScience"},{"issue":"7","key":"567_CR59","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/s42255-024-01049-0","volume":"6","author":"D Jimenez-Blasco","year":"2024","unstructured":"Jimenez-Blasco D, Agulla J, Lapresa R, Garcia-Macia M, Bobo-Jimenez V, Garcia-Rodriguez D, et al. Weak neuronal glycolysis sustains cognition and organismal fitness. Nat Metab. 2024;6(7):1253\u201367.","journal-title":"Nat Metab"},{"issue":"2","key":"567_CR60","first-page":"16","volume":"2024","author":"S Liu","year":"2024","unstructured":"Liu S, Chen H, He XD, Yang XO. Glucometabolic-related genes as diagnostic biomarkers and therapeutic targets for Alzheimer\u2019s Disease and type 2 diabetes mellitus: a bioinformatics analysis. Neurol Res Int. 2024;2024(2):16\u201332.","journal-title":"Neurol Res Int"},{"issue":"11","key":"567_CR61","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1038\/s41380-025-03095-w","volume":"30","author":"S Kumar","year":"2025","unstructured":"Kumar S, Ramos E, Hidalgo A, Rodarte D, Sharma B, Torres MM, et al. Integrated multi-omics analyses of synaptosomes revealed synapse-associated novel targets in Alzheimer\u2019s disease. Mol Psychiatry. 2025;30(11):5121\u201336.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"567_CR62","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","volume":"39","author":"KC Patra","year":"2014","unstructured":"Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014;39(8):347\u201354.","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"567_CR63","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.4049\/jimmunol.162.3.1466","volume":"162","author":"K Banki","year":"1999","unstructured":"Banki K, Hutter E, Gonchoroff NJ, Perl A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J Immunol. 1999;162(3):1466\u201379.","journal-title":"J Immunol"},{"key":"567_CR64","doi-asserted-by":"publisher","first-page":"34648","DOI":"10.1038\/srep34648","volume":"6","author":"T Moriyama","year":"2016","unstructured":"Moriyama T, Tanaka S, Nakayama Y, Fukumoto M, Tsujimura K, Yamada K, et al. Two isoforms of TALDO1 generated by alternative translational initiation show differential nucleocytoplasmic distribution to regulate the global metabolic network. Sci Rep. 2016;6:34648.","journal-title":"Sci Rep"},{"issue":"1","key":"567_CR65","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jimd.12036","volume":"42","author":"M Williams","year":"2019","unstructured":"Williams M, Valayannopoulos V, Altassan R, Chung WK, Heijboer AC, Keng WT, et al. Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: Update of 34 patients. J Inherit Metab Dis. 2019;42(1):147\u201358.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"567_CR66","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener. 2020;15(1):30.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"567_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrn3156","volume":"13","author":"ZH Sheng","year":"2012","unstructured":"Sheng ZH, Cai Q. Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci. 2012;13(2):77\u201393.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"567_CR68","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s43587-025-00869-3","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Chen H, Feng Y, Liu M, Lu Z, Hu B, et al. Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice. Nat Aging. 2025;5(6):1097\u2013113.","journal-title":"Nat Aging"},{"issue":"1","key":"567_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","volume":"19","author":"M Tzioras","year":"2023","unstructured":"Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL. Synaptic degeneration in Alzheimer disease. Nat Rev Neurol. 2023;19(1):19\u201338.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"567_CR70","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrn.2018.19","volume":"19","author":"PJ Magistretti","year":"2018","unstructured":"Magistretti PJ, Allaman I. Lactate in the brain: from metabolic end-product to signalling molecule. Nat Rev Neurosci. 2018;19(4):235\u201349.","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"567_CR71","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/s42255-022-00643-4","volume":"4","author":"L Leng","year":"2022","unstructured":"Leng L, Yuan Z, Pan R, Su X, Wang H, Xue J, et al. Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to beta-amyloid clearance. Nat Metab. 2022;4(10):1287\u2013305.","journal-title":"Nat Metab"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00567-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00567-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00567-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:12:41Z","timestamp":1785521561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40035-026-00567-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1186\/s40035-026-00567-z","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human brain samples were obtained from the Netherlands Brain Bank with informed consent and approval from the Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (2017\u201377). All animal experiments were approved by the Institutional Animal Care and Use Committee of Shanghai Jiao Tong University School of Medicine (A-2022\u2013043) and conducted in accordance with their guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agreed on the publication of this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"35"}}